Company intelligence / Profile preview

Annalise.ai

Sydney, New South Wales, Australiaannalise.ai ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Annalise.ai’s AI-powered medical imaging solutions have received regulatory clearance in over 40 countries—including the US, UK, Europe, and Southeast Asia—and are used at more than 400 sites worldwide. Their tools have demonstrated improved diagnostic accuracy, reduced false positives/negatives compared to competitors, faster triage of critical cases, and enhanced workflow efficiency for radiologists. The technology is trained on large-scale datasets annotated by expert radiologists.

Modalities: Device (AI-based diagnostic support)
Industry: Medical Imaging

Partnerships

Nuance Communications / MicrosoftI-MED Radiology Network

Beyond the preview

Go deeper on Annalise.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Annalise.ai.

Explore the full profile